002940.SZ · 昂利康
China A-shares · RS rating 4 · As of 2026-10-14
| Price | 21.21 CNY |
|---|---|
| 1-day change | -3.9% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 10 / 22 / 8 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 12 / 17 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -15.7% |
| Distance from 52-week high | +54.9% |
| Market cap (USD) | $699.9M |